weekly cisplatin

DRUG3 trials

Sponsors

Korea Cancer Center Hospital, Seoul National University Hospital, Barretos Cancer Hospital

Conditions

Cervical CancersEpithelial Ovarian CarcinomaFallopian Tube CarcinomaPrimary Peritoneal CarcinomaRadiotherapy; Complications

Phase 1

A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer

CompletedNCT02344095

Seoul National University HospitalEpithelial Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma

Start: 2014-12-31End: 2017-10-31Updated: 2024-07-12

Phase 3

Weekly Versus Three-week Chemoradiation in Patients With Advanced Cervical Cancer

CompletedNCT01097252

Korea Cancer Center HospitalCervical Cancers

Start: 2002-01-31End: 2009-12-31Updated: 2014-05-09

Unknown Phase

Hypofractionated Radiotherapy and Concurrent Cisplatin for Head and Neck Cancer

Barretos Cancer HospitalRadiotherapy; Complications

Start: 2015-01-01End: 2019-08-31Updated: 2018-01-19

Related Papers

Modulated electro‑hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial

Experimental and Therapeutic Medicine2021-05-213 citations

A phase I trial evaluating the safety and efficacy of weekly paclitaxel or cisplatin with electro-hyperthermia in patients with recurrent or persistent epithelial ovarian, fallopian tubal or primary peritoneal carcinoma (KGOG 3030).

Journal of Clinical Oncology2019-05-20

Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma

BMC Cancer2018-10-2339 citations